Congress has appropriated about $437 billion for military operations in Iraq and Afghanistan through FY 2006, according to a newly updated report from the Congressional Research Service.
See “The Cost of Iraq, Afghanistan, and Other Global War on Terror Operations Since 9/11” (pdf), updated September 22, 2006.
Some other notable new CRS reports that have not been made readily available to the public include these (all pdf):
“National Security Surveillance Act of 2006: S. 3886, Title II (S. 2453 as Reported Out of the Senate Judiciary Committee),” September 15, 2006.
“Bangladesh: Background and U.S. Relations,” September 7, 2006.
“Terrorist Watchlist Checks and Air Passenger Prescreening,” September 6, 2006.
“Cuba: U.S. Restrictions on Travel and Remittances,” updated August 30, 2006.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.